{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:38:21Z","timestamp":1754163501186,"version":"3.41.2"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>A 61-year-old man with prostate cancer underwent <jats:sup>68<\/jats:sup>Ga-labeled DOTA-ibandronic acid (<jats:sup>68<\/jats:sup>Ga-DOTA-IBA) PET\/CT scan. The examination showed no bone metastases. Incidentally, uptake of <jats:sup>68<\/jats:sup>Ga-DOTA-IBA increased in the lymph node metastases of the left neck.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005786","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T14:00:13Z","timestamp":1740492013000},"page":"867-868","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Increased Uptake of 68Ga-DOTA-IBA in Lymph Node Metastases of Prostate Cancer"],"prefix":"10.1097","volume":"50","author":[{"given":"Na","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1364311","DOI":"10.3389\/fonc.2024.1364311","article-title":"Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis","volume":"14","author":"Deng","year":"2024","journal-title":"Front Oncol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"1428498","DOI":"10.3389\/fonc.2024.1428498","article-title":"Prospective comparison of 68Ga-DOTA-ibandronate and bone scans for detecting bone metastases in breast cancer","volume":"14","author":"Xiang","year":"2024","journal-title":"Front Oncol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/RLU.0000000000005462","article-title":"Increased uptake of 68Ga-DOTA-IBA in multiple subcutaneous metastases of prostate cancer","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/RLU.0000000000005415","article-title":"Incidental uptake of 68Ga-DOTA-IBA in prostate adenocarcinoma","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/RLU.0000000000005200","article-title":"68Ga-DOTA-IBA uptake in breast cancer","volume":"49","author":"Xiang","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2214\/AJR.14.13914","article-title":"Extraosseous findings on bone scintigraphy using fusion SPECT\/CT and correlative imaging","volume":"205","author":"Wale","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09553002.2023.2242935","article-title":"Extraosseous distribution of 99mTc-diphosphonates during bone scintigraphy: review of the literature with case series presentation","volume":"100","author":"Conte","year":"2024","journal-title":"Int J Radiat Biol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/RLU.0000000000004634","article-title":"Safety and efficacy of 68Ga- or 177Lu-labeled DOTA-IBA as a novel theranostic radiopharmaceutical for bone metastases: a phase 0\/I study","volume":"48","author":"Qiu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1021\/acs.molpharmaceut.2c00978","article-title":"Lutetium177-labeled DOTA-ibandronate: a novel radiopharmaceutical for targeted treatment of bone metastases","volume":"20","author":"Wang","year":"2023","journal-title":"Mol Pharm"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/RLU.0000000000005193","article-title":"Treatment of bone metastases of breast cancer With 177Lu-DOTA-IBA","volume":"49","author":"Deng","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/RLU.0000000000004717","article-title":"177Lu-DOTA-IBA therapy in prostate cancer with bone metastases","volume":"48","author":"Li","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:21Z","timestamp":1753938021000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005786","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"2024-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}